Please provide your email address to receive an email when new articles are posted on . Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for ...

The testing service providers hope the legislation, which would reform the CMS’ reimbursement rate-setting process, can cross ...

HSBC on Thursday upgraded Labcorp Holdings (LH) to Buy from Hold and raised its price target to $410 from $330 per share, expecting its P/E multiple to rise further, driven by the company’s M&A ...

Labcorp Holdings (NYSE:LH) and Quest Diagnostics (NYSE:DGX) were among some of the major publicly traded healthcare companies that acknowledged disruption from a global tech outage caused by a bug in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...